Facebook Pixel Code

Dr. Lal Pathlabs Share Price

NSE
BSE

DR. LAL PATHLABS

Midcap | BSE

Here's the live share price of Dr. Lal Pathlabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,589.40 Closed
-3.75₹ -62.00
As on May 12, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Dr. Lal Pathlabs Price Performance

Today's LowToday's High
₹1,581.50₹1,654.35
₹1,589.40
52 Weeks' Low52 Weeks' High
₹1,272.00₹1,771.30
₹1,589.40
Open Price
₹1,652.25
Prev. Close
₹1,651.40
Volume
15,378

Dr. Lal Pathlabs Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Dr. Lal Pathlabs
3.4315.1210.803.2512.9815.852.79
Apollo Hospitals Enterprise
3.276.786.476.9815.9720.3120.21
Max Healthcare Institute
1.796.99-4.26-7.77-12.3826.7535.40
Fortis Healthcare
0.1311.792.41-1.9340.5252.0332.74
Aster DM Healthcare
-1.789.5720.937.0833.1142.3236.19
Narayana Hrudayalaya
4.394.01-1.284.503.2534.1634.94
Global Health
1.9112.454.031.56-2.8729.8523.48
Krishna Institute of Medical Sciences
11.0714.177.439.2114.9936.0530.39
Dr. Agarwals Health Care
-0.464.63-1.00-11.0323.414.172.48
Vijaya Diagnostic Centre
9.1629.3828.6824.9029.1250.6515.64
Rainbow Childrens Medicare
2.621.096.11-4.99-4.6014.9423.44
Metropolis Healthcare
8.3018.5610.4611.1527.9517.40-1.52
Park Medi World
2.0317.0541.5564.7764.7718.1110.50
Healthcare Global Enterprises
-2.849.291.65-19.174.8629.8225.83
Jupiter Life Line Hospitals
0.37-1.13-1.96-17.16-13.424.662.77
Yatharth Hospital & Trauma Care Services
-0.308.5817.7910.5169.0434.8419.64
Thyrocare Technologies
9.9019.8718.311.9149.6845.166.68
Kovai Medical Center and Hospital
-3.060.160.28-10.61-4.0739.3832.47
Nephrocare Health Services
7.830.290.5422.7422.747.074.18
Artemis Medicare Services
7.3118.5810.580.396.9448.0359.21

Over the last one year, Dr. Lal Pathlabs has gained 12.98% compared to peers like Apollo Hospitals Enterprise (15.97%), Max Healthcare Institute (-12.38%), Fortis Healthcare (40.52%). From a 5 year perspective, Dr. Lal Pathlabs has underperformed peers relative to Apollo Hospitals Enterprise (20.21%) and Max Healthcare Institute (35.40%).

Dr. Lal Pathlabs Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Dr. Lal Pathlabs Stock Technicals

Moving Average

DaySMAEMA
51,583.031,599.2
101,491.741,545.73
201,454.71,488.7
501,397.531,436.77
1001,410.81,436.54
2001,497.891,451.58

Dr. Lal Pathlabs Share Holding Pattern

In the latest quarter, Dr. Lal Pathlabs remained same as its previous close in promoter holding, while DII stake increased to 21.37%, FII holding fell to 17.18%, and public shareholding moved up to 7.88% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Dr. Lal Pathlabs Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
41,78,4510.6548.25
25,60,2501.64335.93
15,16,4840.43198.98
13,00,0000.49170.57
12,90,9700.27169.39
12,18,2242.02159.84
11,40,0001.02149.58
10,54,9171.16138.42
7,77,6161.05102.03
7,50,0000.9498.41

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Dr. Lal Pathlabs Corporate Actions

Date Time
Announcement
May 06, 2026, 11:42 PM IST ISTDr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
May 02, 2026, 12:48 AM IST ISTDr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Updates on Acquisition
May 01, 2026, 12:40 AM IST ISTDr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Apr 30, 2026, 09:40 PM IST ISTDr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Investor Presentation
Apr 30, 2026, 09:37 PM IST ISTDr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release

About Dr. Lal Pathlabs

Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 2647.60 Cr. and Equity Capital is Rs. 167.60 Cr. for the Year ended 31/03/2026.

Management

  • Brig.(Hony) Dr. Arvind Lal
    Executive Chairman
  • Dr. Vandana Lal
    Whole Time Director
  • Dr. Archana Lal Erdmann
    Non Executive Director
  • Mr. Rahul Sharma
    Non Executive Director
  • Mr. Arun Duggal
    Independent Director
  • Mr. Gurinder Singh Kalra
    Independent Director
  • Mr. Rajit Mehta
    Independent Director
  • Mrs. Somya Satsangi
    Independent Director
  • Mr. Rohit Bhasin
    Independent Director

FAQs on Dr. Lal Pathlabs Share Price

What is the share price of Dr. Lal Pathlabs?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Lal Pathlabs is ₹1,589.40 as on May 12, 2026.

What kind of stock is Dr. Lal Pathlabs?

The Dr. Lal Pathlabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.

What is the Market Cap of Dr. Lal Pathlabs?

The market cap of Dr. Lal Pathlabs is ₹26,644.35 Cr as on May 12, 2026.

What are today's High and Low prices of Dr. Lal Pathlabs?

Today’s highest and lowest price of Dr. Lal Pathlabs are ₹1,654.35 and ₹1,581.50.

What are the 52 Week High and 52 Week Low of Dr. Lal Pathlabs?

The 52-week high/low is the highest and lowest price at which Dr. Lal Pathlabs stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Lal Pathlabs is ₹1,771.30 and 52-week low of Dr. Lal Pathlabs is ₹1,272.00 as on May 12, 2026.

How has the Dr. Lal Pathlabs performed historically in terms of returns?

The Dr. Lal Pathlabs has shown returns of -3.75% over the past day, 15.12% for the past month, 10.8% over 3 months, 12.98% over 1 year, 15.85% across 3 years, and 2.79% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Dr. Lal Pathlabs?

P/E ratio of and PB ratio of Dr. Lal Pathlabs are 52.78 and 10.40 on May 12, 2026. While the company gives a dividend yield of 0.00 per annum.

icon
Market Pulse